Statement By Mike Leavitt Secretary of Health and Human Services Regarding Senate HELP Committee Action on Dr. Andrew Von Eschenbach To Be New FDA Commissioner
Posted on: Wednesday, 20 September 2006, 15:01 CDT
WASHINGTON, Sept. 20 /PRNewswire/ -- The following is a statement by Mike Leavitt Secretary of Health and Human Services regarding Senate HELP Committee Action on Dr. Andrew von Eschenbach to be new FDA Commissioner:
I am pleased that the Senate HELP Committee acted today to approve the nomination of Dr. Andrew von Eschenbach to be Commissioner of the Food and Drug Administration (FDA) and to send the nomination for further action by the full Senate. Andy has ably led the FDA as its acting commissioner since September 2005, and he is an inspired leader whose devotion to public service is driven by his passion for the care of patients and for finding cures through research. I look forward to his confirmation by the full Senate, as the nation is best served by permanent leadership at the FDA.
Note: All HHS press releases, fact sheets and other press materials are available at http://www.hhs.gov/news.
U.S. Department of Health and Human Services
CONTACT: HHS Press Office, +1-202-690-6343
Web site: http://www.hhs.gov/
Source: PRNewswire
Related Articles
- FDA Commissioner Addresses Nation's Doctors on H1N1 Vaccine
- FDA Issues Strategic Plan for Risk Communication
- Obama Selects FDA Chief, Announces New Food Safety Measures
- FDA Launches New Web Page, E-Newsletter to Enhance Online Consumer Health Information
- Von Eschenbach to Be Tapped As FDA Head
- Embattled FDA Commissioner Crawford Quits
- Embattled FDA Commissioner Resigns
- Besieged FDA Chief Abruptly Resigns
- Conflict Concerns Raised on FDA Panels; Senate Worried About Scientists' Ties
- FDA Ignores Its Whistleblowers, New Report Says
 |
 |
User Comments (0)
RSS Feeds